PATENT CLAIM ANALYSIS

Application Number: 16043639
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are methods for performing cellular reprogramming that include treatment of somatic cells with an inhibitor of CAF-1, Sumo2, Nutd21, or combinations thereof prior to or during a reprogramming procedure. Such inhibitors can improve both the speed and efficiency of cellular reprogramming. Inhibitors of the CAF-1 complex can also be used in the treatment of cancer.

Claim (Index 1):
A method of inducing differentiation of a cancer cell or cancer stem cell in vivo, the method comprising: administering an inhibitor of the CAF-1 complex to a subject having, or suspected of having cancer, thereby inducing differentiation of the cancer cell or cancer stem cell in vivo.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.36957
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15443632', '14256668', '14904195', '13394481', '15148230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.716895273084789
- 35 USC 102 Novelty (BERT): 0.6126815107851692
- Combined Prediction Score: 0.706473896854827
- Mean Citation Score: 330.304806
- Max Citation Score: 675.5881
- Similarity Product: 444.2105507079481

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test